{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:51:07Z","timestamp":1790398267988,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jiac.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T11:30:22Z","timestamp":1493119822000},"page":"572-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-7449","authenticated-orcid":false,"given":"Kunio","family":"Yanagisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Hosogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Todokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeki","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yokohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.03.002_bib1","first-page":"1","volume":"vol 63","author":"CDC","year":"2014"},{"key":"10.1016\/j.jiac.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00006982-200507000-00015","article-title":"HIV-associated retinopathy in the HAART era","volume":"25","author":"Goldberg","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.jiac.2017.03.002_bib3","article-title":"Viral posterior uveitis","author":"Lee","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jiac.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2016.03.015","article-title":"Long-term follow-up of cytomegalovirus retinitis in non-HIV immunocompromised patients: clinical features and visual prognosis","volume":"165","author":"Iu","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jiac.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00006982-199515020-00015","article-title":"Cytomegalovirus retinitis in a patient with rheumatoid arthritis being treated with combination immunosuppressive therapy","volume":"15","author":"Fraenkel","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.jiac.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archopht.1986.01050200023017","article-title":"Accelerated cytomegalovirus retinitis secondary to immunosuppressive therapy","volume":"104","author":"Scott","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jiac.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/425123","article-title":"Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis","volume":"39","author":"Haerter","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.eye.6701941","article-title":"Occurrence and reactivation of cytomegalovirus retinitis in systemic lupus erythematosus with normal CD4(+) counts","volume":"20","author":"Lee","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jiac.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/ciq112","article-title":"Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses","volume":"52","author":"Hartigan-O'Connor","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"971417","DOI":"10.1155\/2014\/971417","article-title":"Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment","volume":"2014","author":"Urban","year":"2014","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jiac.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00417-014-2587-5","article-title":"Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection","volume":"252","author":"Agarwal","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jiac.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1182\/blood-2002-05-1387","article-title":"Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells","volume":"100","author":"Ozdemir","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jiac.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jb\/mvv069","article-title":"Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside","volume":"158","author":"Tanaka","year":"2015","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.jiac.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/ket466","article-title":"Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events","volume":"53","author":"Sonomoto","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.jiac.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-9255-7-41","article-title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","volume":"7","author":"Meyer","year":"2010","journal-title":"J\u00a0Inflamm (Lond)"},{"key":"10.1016\/j.jiac.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/annrheumdis-2016-209131","article-title":"Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis","volume":"75","author":"Curtis","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:52Z","timestamp":1761159412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1341321X17300491"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.03.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}